Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

30 closest matches · ranked by relevance

N/A N=68 Everyday Memory Intervention

Aging
Primary: Everyday Memory Failures — 0.55; 0.62 average daily number memory failures/day — p=.67
Georgia Institute of Technology Results May 2024 0.0% serious AE View details

N/A N=38 tDCS and Cognitive Efficiency in Ageing

Aging · Mild Cognitive Impairment · Alzheimer Disease
Primary: Complutense Verbal Learning Test (TAVEC) - Memory — 0.94; -0.81; 1.65; -0.31 units on a scale
University of Valencia Results Dec 2024 0.0% serious AE View details

Phase 2 N=50 Riluzole in Mild Alzheimer's Disease

Alzheimer's Disease
Primary: Imaging Biomarkers FDG-PET SUVR in Regions of Interest — -0.048; -0.005; -0.032; -0.007 Standardized Uptake Value Ratios (SUVRs)
Icahn School of Medicine at Mount Sinai Results Sep 2021 6.0% serious AE View details

N/A N=140 Noradrenergic Activity and Attention

Aging
Primary: Initial Eye-movements Toward Target and Distractor Shapes Measured by an Eye-tracker — 3.8; 4.4; 3.6; 4.5 percentage of first saccades
University of Southern California Results Sep 2024 0.0% serious AE View details

Phase 2 N=30 The Efficient Brain Study

Metabolism - Cerebral Energy
Primary: Magnetic Resonance Spectroscopy (MRS) Will Measure a Change in Cerebral Energy Function in Brain Tissue — .011; .007; .009; .006 Difference in metabolite amplitude
University of Florida Results Oct 2019 3.3% serious AE View details